Renaissance Technologies’s Cross Country Healthcare CCRN Stock Holding History

Renaissance Technologies’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.31M	Buy	245,400 +30,800	+14%	+$276K	﹤0.01%	1826
2025 Q4	$1.74M	Buy	214,600 +11,600	+6%	+$127K	﹤0.01%	1953
2025 Q3	$2.88M	Sell	203,000 -85,983	-30%	-$1.14M	﹤0.01%	1828
2025 Q2	$3.77M	Buy	288,983 +113,965	+65%	+$1.57M	0.01%	1698
2025 Q1	$2.61M	Buy	175,018 +86,818	+98%	+$1.49M	﹤0.01%	1840
2024 Q4	$1.6M	Sell	88,200 -166,099	-65%	-$2.24M	﹤0.01%	2195
2024 Q3	$3.42M	Buy	254,299 +161,790	+175%	+$2.39M	0.01%	1689
2024 Q2	$1.28M	Buy	92,509 +64,091	+226%	+$1.01M	﹤0.01%	2179
2024 Q1	$532K	Buy	28,418 +8,632	+44%	+$173K	﹤0.01%	2836
2023 Q4	$448K	Sell	19,786 -165,044	-89%	-$3.58M	﹤0.01%	2831
2023 Q3	$4.58M	Sell	184,830 -65,088	-26%	-$1.64M	0.01%	1358
2023 Q2	$7.02M	Sell	249,918 -353,300	-59%	-$8.77M	0.01%	1213
2023 Q1	$13.5M	Buy	603,218 +106,300	+21%	+$2.78M	0.02%	923
2022 Q4	$13.2M	Buy	496,918 +427,900	+620%	+$14M	0.02%	942
2022 Q3	$1.96M	Buy	+69,018	New	+$1.77M	﹤0.01%	2025
2022 Q2	–	Sell	-56,618	Closed	-$1.23M	–	4244
2022 Q1	$1.23M	Sell	56,618 -110,900	-66%	-$2.41M	﹤0.01%	2592
2021 Q4	$4.65M	Buy	167,518 +38,900	+30%	+$943K	0.01%	1580
2021 Q3	$2.73M	Sell	128,618 -63,161	-33%	-$1.18M	﹤0.01%	1863
2021 Q2	$3.17M	Buy	191,779 +142,661	+290%	+$2.18M	﹤0.01%	1928
2021 Q1	$613K	Sell	49,118 -104,700	-68%	-$1.11M	﹤0.01%	2829
2020 Q4	$1.36M	Sell	153,818 -57,420	-27%	-$467K	﹤0.01%	2346
2020 Q3	$1.37M	Buy	211,238 +119,382	+130%	+$757K	﹤0.01%	2331
2020 Q2	$566K	Sell	91,856 -202,526	-69%	-$1.24M	﹤0.01%	2825
2020 Q1	$1.98M	Sell	294,382 -164,548	-36%	-$1.56M	﹤0.01%	2052
2019 Q4	$5.33M	Buy	458,930 +226,930	+98%	+$2.56M	﹤0.01%	1810
2019 Q3	$2.39M	Buy	232,000 +156,500	+207%	+$1.54M	﹤0.01%	2189
2019 Q2	$708K	Buy	75,500 +53,700	+246%	+$413K	﹤0.01%	2859
2019 Q1	$153K	Buy	21,800 +8,000	+58%	+$68.6K	﹤0.01%	3245
2018 Q4	$101K	Buy	+13,800	New	+$116K	﹤0.01%	3230
2018 Q1	–	Sell	-12,200	Closed	-$156K	–	3381
2017 Q4	$156K	Buy	+12,200	New	+$161K	﹤0.01%	3170
2017 Q1	–	Sell	-158,018	Closed	-$2.47M	–	3240
2016 Q4	$2.47M	Buy	158,018 +112,101	+244%	+$1.54M	﹤0.01%	2112
2016 Q3	$541K	Sell	45,917 -92,401	-67%	-$1.22M	﹤0.01%	2786
2016 Q2	$1.93M	Sell	138,318 -196,800	-59%	-$2.61M	﹤0.01%	2212
2016 Q1	$3.9M	Sell	335,118 -135,500	-29%	-$1.72M	0.01%	1798
2015 Q4	$7.71M	Buy	470,618 +138,400	+42%	+$2.2M	0.02%	1168
2015 Q3	$4.52M	Buy	332,218 +314,318	+1,756%	+$4.27M	0.01%	1458
2015 Q2	$227K	Sell	17,900 -10,500	-37%	-$119K	﹤0.01%	2955
2015 Q1	$337K	Sell	28,400 -34,300	-55%	-$393K	﹤0.01%	2722
2014 Q4	$782K	Sell	62,700 -89,100	-59%	-$910K	﹤0.01%	2263
2014 Q3	$1.41M	Sell	151,800 -73,400	-33%	-$563K	﹤0.01%	1849
2014 Q2	$1.47M	Sell	225,200 -297,402	-57%	-$1.97M	﹤0.01%	1885
2014 Q1	$4.22M	Buy	522,602 +238,084	+84%	+$2.34M	0.01%	1354
2013 Q4	$2.84M	Buy	284,518 +219,098	+335%	+$1.52M	0.01%	1550
2013 Q3	$395K	Sell	65,420 -30,607	-32%	-$175K	﹤0.01%	2380
2013 Q2	$495K	Buy	+96,027	New	+$492K	﹤0.01%	2242

Other funds holding CCRN

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

DIA

Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Renaissance Technologies's CCRN Position: Q1 2026 in Review

Renaissance Technologies increased its Cross Country Healthcare (CCRN) stake by 14% in Q1 2026, buying an estimated $276K and bringing the position to 245,400 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Renaissance Technologies first reported a position in CCRN in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.5M in Q1 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

Renaissance Technologies held 245,400 shares of Cross Country Healthcare worth $2.31M as of Q1 2026.
Renaissance Technologies bought 30,800 Cross Country Healthcare shares in Q1 2026, an estimated $276K.
Cross Country Healthcare made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1826 holding.
Renaissance Technologies first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 45 quarters since.
Renaissance Technologies's Cross Country Healthcare position peaked at $13.5M in Q1 2023.
151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.